US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ATYR PHARMA INC

0.4754

+0.00701.49%

Post-market: 0.4606-0.0148-3.11%19:37 EDT

Volume:1.23M

Turnover:570.71K

Market Cap:46.58M

PE:-0.65

High:0.4800

Open:0.4690

Low:0.4400

Close:0.4684

52wk High:7.29

52wk Low:0.3950

Shares:97.99M

Float Shares:95.97M

Volume Ratio:0.70

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7304

EPS(LYR):-0.7971

ROE:-105.63%

ROA:-51.79%

PB:0.80

PE(LYR):-0.60

Loading ...

Overview Company News Filings

aTyr Pharma Inc options imply 14.1% move in share price post-earnings

aTyr Pharma Inc expected to post a loss of 15 cents a share - Earnings Preview

BRIEF-aTyr Pharma Q1 Net Income USD -166.391 Million

aTyr Pharma Q1 Income From Operations USD -163.314 Million

THOMSON REUTERS

aTyr Pharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX)

Atyr Pharma Faces Nasdaq Delisting Risk After Minimum Bid Price Violation

aTyr Pharma Q4 EPS $(0.14) Beats $(0.16) Estimate

aTyr posts FY 2025 net loss of USD 74.1 million

aTyr Pharma Inc: Qtrly Shr Loss $0.14

THOMSON REUTERS

Press Release: aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

aTyr Pharma Awards Inducement Stock Options Under Nasdaq Rule 5635(c)(4)

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

BRIEF-Atyr Pharma Announces Scheduling Of FDA Type C Meeting To Discuss Efzofitimod Program In Pulmonary Sarcoidosis

aTyr Pharma Inc - Type C Meeting Scheduled for Mid-April 2026

THOMSON REUTERS

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATYR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATYR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATYR\",,,,,undefined,":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":0.4754,"timestamp":1781208000000,"preClose":0.4684,"halted":0,"volume":1230505,"hourTrading":{"tag":"盘后","latestPrice":0.4606,"preClose":0.4754,"latestTime":"19:37 EDT","volume":11197,"amount":5222.10085,"timestamp":1781221036341,"change":-0.0148,"changeRate":-0.031132,"amplitude":0.056794},"delay":0,"changeRate":0.014944491887275847,"floatShares":95966000,"shares":97986634,"eps":-0.730419,"marketStatus":"Closed","change":0.007,"latestTime":"06-11 16:00:00 EDT","open":0.469,"high":0.48,"low":0.44,"amount":570712.56268265,"amplitude":0.085397,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.730419,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781251200000},"marketStatusCode":5,"adr":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":0.4684,"preHourTrading":{"tag":"盘前","latestPrice":0.4663,"preClose":0.4684,"latestTime":"09:21 EDT","volume":3383,"amount":1564.29432848,"timestamp":1781184068749,"change":-0.0021,"changeRate":-0.004483,"amplitude":0.054014},"postHourTrading":{"tag":"盘后","latestPrice":0.4606,"preClose":0.4754,"latestTime":"19:37 EDT","volume":11197,"amount":5222.10085,"timestamp":1781221036341,"change":-0.0148,"changeRate":-0.031132,"amplitude":0.056794},"volumeRatio":0.700579,"impliedVol":3.1477,"impliedVolPercentile":0.8526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATYR\",,,,,undefined,":{"symbol":"ATYR","floatShares":95966000,"roa":"-51.79%","roe":"-105.63%","lyrEps":-0.797093,"volumeRatio":0.700579,"shares":97986634,"dividePrice":0,"high":0.48,"amplitude":0.085397,"preClose":0.4684,"low":0.44,"week52Low":0.395,"pbRate":"0.80","psRate":"245.17","week52High":7.2904,"institutionHeld":0,"latestPrice":0.4754,"eps":-0.730419,"divideRate":0,"volume":1230505,"delay":0,"ttmEps":-0.730419,"open":0.469,"prevYearClose":0.7831,"prevWeekClose":0.47,"prevMonthClose":0.5425,"prevQuarterClose":0.78,"fiveDayClose":0.513,"twentyDayClose":0.3959,"sixtyDayClose":0.8815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATYR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"ATYR","fiscalQuarterEnding":"2026/03","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2026-03-05","symbol":"ATYR","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-11-06","symbol":"ATYR","fiscalQuarterEnding":"2025/09","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-08-07","symbol":"ATYR","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2025-05-07","symbol":"ATYR","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATYR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATYR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.3333,"hold":0.5556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1779336000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATYR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATYR","date":"2026-06-10","current":-0.653392,"percent":0.995868,"low":-9.277729,"twenty":-5.07473,"median":-2.474305,"eighty":-1.079438,"high":-0.523739,"avg":-3.350921,"sd":2.318796,"marketCap":44672132},"quantilePoints":[{"date":"2024-06-07","current":-2.380173,"twenty":-2.380173,"median":-2.380173,"eighty":-2.380173,"marketCap":128360348},{"date":"2024-06-14","current":-2.367376,"twenty":-2.482546,"median":-2.431359,"eighty":-2.377614,"marketCap":127670239},{"date":"2024-06-21","current":-2.021867,"twenty":-2.446715,"median":-2.367376,"eighty":-2.203579,"marketCap":109037285},{"date":"2024-06-28","current":-1.970681,"twenty":-2.431359,"median":-2.367376,"eighty":-2.111444,"marketCap":106276847},{"date":"2024-07-05","current":-1.970681,"twenty":-2.431359,"median":-2.265003,"eighty":-1.991155,"marketCap":106276847},{"date":"2024-07-12","current":-2.073054,"twenty":-2.39041,"median":-2.092249,"eighty":-1.970681,"marketCap":111797722},{"date":"2024-07-15","current":-2.226613,"twenty":-2.380173,"median":-2.111444,"eighty":-1.970681,"marketCap":120079035},{"date":"2024-08-02","current":-2.495343,"twenty":-2.421122,"median":-2.130639,"eighty":-1.9758,"marketCap":134571333},{"date":"2024-08-09","current":-2.380173,"twenty":-2.403207,"median":-2.265003,"eighty":-1.996274,"marketCap":128360348},{"date":"2024-08-16","current":-2.618312,"twenty":-2.418704,"median":-2.296995,"eighty":-2.001393,"marketCap":151592396},{"date":"2024-08-23","current":-2.448121,"twenty":-2.445503,"median":-2.341783,"eighty":-2.021867,"marketCap":141738890},{"date":"2024-08-30","current":-2.474305,"twenty":-2.468042,"median":-2.373775,"eighty":-2.032104,"marketCap":143254814},{"date":"2024-09-06","current":-2.291023,"twenty":-2.461213,"median":-2.354579,"eighty":-2.073054,"marketCap":132643346},{"date":"2024-09-13","current":-2.448121,"twenty":-2.474305,"median":-2.380173,"eighty":-2.111444,"marketCap":141738890},{"date":"2024-09-20","current":-2.448121,"twenty":-2.474305,"median":-2.399368,"eighty":-2.149834,"marketCap":141738890},{"date":"2024-09-27","current":-2.277931,"twenty":-2.474305,"median":-2.382664,"eighty":-2.226613,"marketCap":131885384},{"date":"2024-10-04","current":-2.277931,"twenty":-2.469749,"median":-2.373775,"eighty":-2.226613,"marketCap":131885384},{"date":"2024-10-11","current":-2.77541,"twenty":-2.474305,"median":-2.382664,"eighty":-2.251748,"marketCap":160687939},{"date":"2024-10-18","current":-3.469263,"twenty":-2.48085,"median":-2.399368,"eighty":-2.251748,"marketCap":200859924},{"date":"2024-10-25","current":-4.241665,"twenty":-2.500488,"median":-2.421938,"eighty":-2.265003,"marketCap":245579681},{"date":"2024-10-31","current":-4.097658,"twenty":-2.555472,"median":-2.431359,"eighty":-2.275241,"marketCap":237242099},{"date":"2024-11-08","current":-4.058383,"twenty":-2.922036,"median":-2.441575,"eighty":-2.277905,"marketCap":234968213},{"date":"2024-11-15","current":-3.78886,"twenty":-3.621287,"median":-2.448121,"eighty":-2.277931,"marketCap":241789871},{"date":"2024-11-22","current":-3.919838,"twenty":-3.629704,"median":-2.448121,"eighty":-2.277931,"marketCap":250148372},{"date":"2024-11-29","current":-4.643298,"twenty":-3.916561,"median":-2.461213,"eighty":-2.285786,"marketCap":296316696},{"date":"2024-12-06","current":-4.301299,"twenty":-4.007344,"median":-2.474305,"eighty":-2.298878,"marketCap":274491670},{"date":"2024-12-13","current":-3.972453,"twenty":-4.100191,"median":-2.474305,"eighty":-2.31136,"marketCap":253506069},{"date":"2024-12-20","current":-4.143453,"twenty":-4.111931,"median":-2.474305,"eighty":-2.3168,"marketCap":264418582},{"date":"2024-12-27","current":-4.95899,"twenty":-4.144489,"median":-2.487396,"eighty":-2.317206,"marketCap":316462874},{"date":"2025-01-03","current":-5.143143,"twenty":-4.229494,"median":-2.500488,"eighty":-2.317206,"marketCap":328214811},{"date":"2025-01-10","current":-4.919528,"twenty":-4.267848,"median":-2.526671,"eighty":-2.317206,"marketCap":313944602},{"date":"2025-01-17","current":-4.932682,"twenty":-4.327606,"median":-2.579037,"eighty":-2.328986,"marketCap":314784026},{"date":"2025-01-24","current":-4.682759,"twenty":-4.341161,"median":-2.768865,"eighty":-2.330035,"marketCap":298834968},{"date":"2025-01-31","current":-4.919528,"twenty":-4.389843,"median":-2.932509,"eighty":-2.330297,"marketCap":313944602},{"date":"2025-02-07","current":-5.090528,"twenty":-4.509129,"median":-3.510289,"eighty":-2.339486,"marketCap":324857115},{"date":"2025-02-14","current":-4.722221,"twenty":-4.606467,"median":-3.575068,"eighty":-2.341783,"marketCap":301353241},{"date":"2025-02-21","current":-5.827142,"twenty":-4.643298,"median":-3.6107,"eighty":-2.357139,"marketCap":371864863},{"date":"2025-02-28","current":-5.090528,"twenty":-4.682759,"median":-3.851618,"eighty":-2.375054,"marketCap":324857115},{"date":"2025-03-07","current":-4.051376,"twenty":-4.682759,"median":-3.972453,"eighty":-2.380173,"marketCap":258542613},{"date":"2025-03-14","current":-5.248373,"twenty":-4.682759,"median":-3.985607,"eighty":-2.381668,"marketCap":334930203},{"date":"2025-03-21","current":-4.929845,"twenty":-4.727483,"median":-3.990774,"eighty":-2.382664,"marketCap":315623450},{"date":"2025-03-28","current":-4.52461,"twenty":-4.75379,"median":-4.035211,"eighty":-2.388848,"marketCap":289679075},{"date":"2025-04-04","current":-3.872289,"twenty":-4.740636,"median":-4.038222,"eighty":-2.400648,"marketCap":247915527},{"date":"2025-04-11","current":-3.802893,"twenty":-4.727483,"median":-4.011134,"eighty":-2.407615,"marketCap":243472596},{"date":"2025-04-17","current":-4.191509,"twenty":-4.722221,"median":-4.035211,"eighty":-2.414083,"marketCap":268353008},{"date":"2025-04-25","current":-4.788314,"twenty":-4.743267,"median":-4.051376,"eighty":-2.421938,"marketCap":306562211},{"date":"2025-05-02","current":-4.635643,"twenty":-4.743267,"median":-4.087671,"eighty":-2.425706,"marketCap":296787764},{"date":"2025-05-09","current":-4.680309,"twenty":-4.75642,"median":-4.108234,"eighty":-2.431359,"marketCap":296787764},{"date":"2025-05-16","current":-4.210769,"twenty":-4.743267,"median":-4.133647,"eighty":-2.432827,"marketCap":267013308},{"date":"2025-05-23","current":-5.333641,"twenty":-4.774836,"median":-4.143453,"eighty":-2.440266,"marketCap":338216856},{"date":"2025-05-30","current":-5.972275,"twenty":-4.816072,"median":-4.149872,"eighty":-2.448121,"marketCap":378713875},{"date":"2025-06-06","current":-7.509205,"twenty":-4.87282,"median":-4.17922,"eighty":-2.448121,"marketCap":476173732},{"date":"2025-06-13","current":-7.621493,"twenty":-4.919528,"median":-4.191509,"eighty":-2.448121,"marketCap":483294087},{"date":"2025-06-20","current":-7.256559,"twenty":-4.932682,"median":-4.241665,"eighty":-2.448121,"marketCap":460152934},{"date":"2025-06-27","current":-7.453062,"twenty":-4.985297,"median":-4.254757,"eighty":-2.448121,"marketCap":472613555},{"date":"2025-07-03","current":-7.453062,"twenty":-5.016231,"median":-4.28094,"eighty":-2.448121,"marketCap":472613555},{"date":"2025-07-11","current":-7.481134,"twenty":-5.080005,"median":-4.302543,"eighty":-2.458595,"marketCap":474393643},{"date":"2025-07-18","current":-8.126785,"twenty":-5.119466,"median":-4.327606,"eighty":-2.461213,"marketCap":515335684},{"date":"2025-07-25","current":-7.796941,"twenty":-5.18655,"median":-4.339852,"eighty":-2.468042,"marketCap":494419641},{"date":"2025-08-01","current":-6.624944,"twenty":-5.237851,"median":-4.345289,"eighty":-2.473394,"marketCap":420100937},{"date":"2025-08-08","current":-7.354811,"twenty":-5.277498,"median":-4.380221,"eighty":-2.474305,"marketCap":466383244},{"date":"2025-08-15","current":-7.337565,"twenty":-5.711388,"median":-4.396173,"eighty":-2.474305,"marketCap":488953303},{"date":"2025-08-22","current":-7.278747,"twenty":-6.338611,"median":-4.472298,"eighty":-2.474305,"marketCap":485033838},{"date":"2025-08-29","current":-7.866928,"twenty":-6.868599,"median":-4.491152,"eighty":-2.474305,"marketCap":524228491},{"date":"2025-09-05","current":-8.043383,"twenty":-7.051635,"median":-4.498606,"eighty":-2.474305,"marketCap":535986887},{"date":"2025-09-12","current":-7.734587,"twenty":-7.202339,"median":-4.538489,"eighty":-2.478232,"marketCap":515409694},{"date":"2025-09-19","current":-1.543977,"twenty":-7.202339,"median":-4.511608,"eighty":-2.474305,"marketCap":102885965},{"date":"2025-09-26","current":-1.313556,"twenty":-7.183573,"median":-4.496851,"eighty":-2.466335,"marketCap":87531460},{"date":"2025-10-03","current":-1.043875,"twenty":-7.138658,"median":-4.477635,"eighty":-2.448121,"marketCap":69560711},{"date":"2025-10-10","current":-1.401343,"twenty":-7.082514,"median":-4.406529,"eighty":-2.442885,"marketCap":93381262},{"date":"2025-10-17","current":-1.470454,"twenty":-7.051635,"median":-4.382946,"eighty":-2.421938,"marketCap":97986634},{"date":"2025-10-24","current":-1.430458,"twenty":-7.012335,"median":-4.346398,"eighty":-2.388848,"marketCap":95321397},{"date":"2025-10-31","current":-1.305763,"twenty":-6.956191,"median":-4.340306,"eighty":-2.375054,"marketCap":87012130},{"date":"2025-11-07","current":-1.004754,"twenty":-6.884883,"median":-4.327606,"eighty":-2.330297,"marketCap":75479104},{"date":"2025-11-14","current":-0.930535,"twenty":-6.741157,"median":-4.315074,"eighty":-2.317206,"marketCap":69903664},{"date":"2025-11-21","current":-0.849664,"twenty":-6.641787,"median":-4.294031,"eighty":-2.285786,"marketCap":63828493},{"date":"2025-11-28","current":-1.018058,"twenty":-6.613715,"median":-4.254757,"eighty":-2.277852,"marketCap":76478567},{"date":"2025-12-05","current":-1.079755,"twenty":-6.467742,"median":-4.247271,"eighty":-2.236667,"marketCap":81113335},{"date":"2025-12-12","current":-0.998232,"twenty":-6.153338,"median":-4.191509,"eighty":-2.08841,"marketCap":74989171},{"date":"2025-12-19","current":-0.9171,"twenty":-5.941396,"median":-4.17922,"eighty":-1.996274,"marketCap":68894402},{"date":"2025-12-26","current":-0.962753,"twenty":-5.88149,"median":-4.159816,"eighty":-1.970681,"marketCap":72323934},{"date":"2026-01-02","current":-1.02145,"twenty":-5.827142,"median":-4.144316,"eighty":-1.58809,"marketCap":76733333},{"date":"2026-01-09","current":-0.945796,"twenty":-5.68245,"median":-4.143453,"eighty":-1.529272,"marketCap":71050108},{"date":"2026-01-16","current":-0.921535,"twenty":-5.590373,"median":-4.115174,"eighty":-1.499863,"marketCap":69227556},{"date":"2026-01-23","current":-0.973579,"twenty":-5.463588,"median":-4.100824,"eighty":-1.470454,"marketCap":73137223},{"date":"2026-01-30","current":-1.109494,"twenty":-5.353291,"median":-4.058383,"eighty":-1.430928,"marketCap":83347430},{"date":"2026-02-06","current":-1.05745,"twenty":-5.277498,"median":-4.044799,"eighty":-1.420105,"marketCap":79437764},{"date":"2026-02-13","current":-1.16206,"twenty":-5.263462,"median":-4.025068,"eighty":-1.381433,"marketCap":87296292},{"date":"2026-02-20","current":-1.369585,"twenty":-5.259961,"median":-3.990774,"eighty":-1.302178,"marketCap":102885965},{"date":"2026-02-27","current":-1.291323,"twenty":-5.252075,"median":-3.985607,"eighty":-1.296092,"marketCap":97006767},{"date":"2026-03-06","current":-1.193659,"twenty":-5.240481,"median":-3.979834,"eighty":-1.286732,"marketCap":88471608},{"date":"2026-03-13","current":-1.147622,"twenty":-5.227328,"median":-3.937701,"eighty":-1.255818,"marketCap":85059426},{"date":"2026-03-20","current":-1.094838,"twenty":-5.211936,"median":-3.872289,"eighty":-1.237152,"marketCap":81147183},{"date":"2026-03-27","current":-1.048668,"twenty":-5.203474,"median":-3.781997,"eighty":-1.214301,"marketCap":77725195},{"date":"2026-04-02","current":-1.125529,"twenty":-5.194443,"median":-3.671031,"eighty":-1.194857,"marketCap":83421971},{"date":"2026-04-10","current":-0.99218,"twenty":-5.16682,"median":-3.600179,"eighty":-1.172887,"marketCap":73538409},{"date":"2026-04-17","current":-1.098674,"twenty":-5.140003,"median":-3.556109,"eighty":-1.163625,"marketCap":81431531},{"date":"2026-04-24","current":-1.047345,"twenty":-5.133171,"median":-3.450357,"eighty":-1.14771,"marketCap":77627144},{"date":"2026-05-01","current":-1.068115,"twenty":-5.124727,"median":-2.847414,"eighty":-1.126799,"marketCap":79166548},{"date":"2026-05-08","current":-1.219456,"twenty":-5.106312,"median":-2.618312,"eighty":-1.12201,"marketCap":90383607},{"date":"2026-05-15","current":-0.740696,"twenty":-5.090528,"median":-2.530202,"eighty":-1.115819,"marketCap":54898873},{"date":"2026-05-22","current":-0.73998,"twenty":-5.090528,"median":-2.500488,"eighty":-1.110669,"marketCap":51820065},{"date":"2026-05-29","current":-0.682434,"twenty":-5.087897,"median":-2.487396,"eighty":-1.099177,"marketCap":47790160},{"date":"2026-06-05","current":-0.718278,"twenty":-5.076713,"median":-2.474305,"eighty":-1.090075,"marketCap":50300271},{"date":"2026-06-10","current":-0.637909,"twenty":-5.07473,"median":-2.474305,"eighty":-1.079438,"marketCap":44672132}],"updateTime":1781204630290},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATYR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634229469","title":"aTyr Pharma Inc options imply 14.1% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2634229469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634229469?lang=en_us&edition=fundamental","pubTime":"2026-05-09 02:51","pubTimestamp":1778266265,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in aTyr Pharma (ATYR) Inc is normal with calls leading puts 22:1. Implied volatility suggests the market is anticipatin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atyr-pharma-inc-options-imply-14-1-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atyr-pharma-inc-options-imply-14-1-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633530934","title":"aTyr Pharma Inc  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633530934","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633530934?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:47","pubTimestamp":1778240860,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc  expected to post a loss of15cents a share - Earnings Preview aTyr Pharma Inc ATYR.OQ ATYR.O is expected to  show no change in quarterly revenue when it reports  results on May 11 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L166:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633519821","title":"BRIEF-aTyr Pharma Q1 Net Income USD -166.391 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633519821","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633519821?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097951,"startTime":"0","endTime":"0","summary":"BRIEF-aTyr Pharma Q1 Net Income USD -166.391 Million\n\n\nMay 06 (Reuters) - aTyr Pharma Q1 basic EPS USD -3.57.\n\nQ1 income from operations USD -163.314 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX4924B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633415940","title":"aTyr Pharma Q1 Income From Operations USD -163.314 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633415940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633415940?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097909,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX4924B6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632611971","title":"aTyr Pharma Inc  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632611971","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632611971?lang=en_us&edition=fundamental","pubTime":"2026-05-01 19:43","pubTimestamp":1777635799,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc  expected to post a loss of15cents a share - Earnings Preview aTyr Pharma Inc ATYR.OQ ATYR.O is expected to  show no change in quarterly revenue when it reports  results on May 5 (esti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E0PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625071366","title":"Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625071366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625071366?lang=en_us&edition=fundamental","pubTime":"2026-04-07 06:30","pubTimestamp":1775514607,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on aTyr Pharma (ATYR) and Idexx Laboratories (IDXX). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-atyr-pharma-atyr-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-atyr-pharma-atyr-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0170899867.USD","ATYR","BK4139","LU0128526141.USD","BK4588","LABU","LU2404859741.USD","LU0690374961.EUR","LU0345774631.USD","BK4082","LU2404859667.USD","LU0029874061.USD","LU1941712264.USD","BK4581","IDXX","BK4585","BK4504","HCSG","XBI","XLV","GB00B4QBRK32.GBP","BK4567","LU0345774391.USD","LU1941712348.USD","LU1989771016.USD","LU0690374615.EUR","LU1291159041.SGD","GB00B4LPDJ14.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617528566","title":"Atyr Pharma Faces Nasdaq Delisting Risk After Minimum Bid Price Violation","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617528566?lang=en_us&edition=fundamental","pubTime":"2026-03-07 14:00","pubTimestamp":1772863234,"startTime":"0","endTime":"0","summary":"Atyr Pharma Inc. (ATYR) has disclosed a new risk, in the Share Price & Shareholder Rights category. Atyr Pharma Inc. faces a significant listing ri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atyr-pharma-faces-nasdaq-delisting-risk-after-minimum-bid-price-violation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atyr-pharma-faces-nasdaq-delisting-risk-after-minimum-bid-price-violation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617754655","title":"aTyr Pharma Q4 EPS $(0.14) Beats $(0.16) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2617754655","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617754655?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:03","pubTimestamp":1772744613,"startTime":"0","endTime":"0","summary":"aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.16) by 13.04 percent. This is a 22.22 percent increase over losses of $(0.18) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51082508/atyr-pharma-q4-eps-0-14-beats-0-16-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"aTyr Pharma Q4 EPS $(0.14) Beats $(0.16) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617751215","title":"aTyr posts FY 2025 net loss of USD 74.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617751215","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617751215?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:02","pubTimestamp":1772744535,"startTime":"0","endTime":"0","summary":"aTyr posts FY 2025 net loss of USD 74.1 million               aTyr Pharma reported a Q4 2025 net loss attributable to shareholders of USD 14.0 million, or USD 0.14 per share (basic and diluted), on no","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLc9fMpk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4588","BK4112","LU2210150020.SGD","BK4585","LU2210149790.SGD","SG9999014013.SGD","ATYR","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014005.SGD","LU2095319765.USD","BK4139","SG9999014039.USD","NDAQ","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617579237","title":"aTyr Pharma Inc: Qtrly Shr Loss $0.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2617579237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617579237?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:01","pubTimestamp":1772744461,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nTUA8PVVNF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617575947","title":"Press Release: aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2617575947","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617575947?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:01","pubTimestamp":1772744460,"startTime":"0","endTime":"0","summary":"Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT study and determine the path forward for efzofitimod in pulmonary sarcoidosis.\"In 2025 we announced results from our Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis, a major form of interstitial lung disease  where a significant proportion of patients develop chronic or progressive disease with debilitating symptoms despite current treatment options. This marked an important milestone, not only for the broader sarcoidosis community, but also for aTyr, as it was the Company's largest and first Phase 3 study of a tRNA synthetase-derived therapy generated from our platform,\" said Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr.\"We are ready and look forward to engaging with the U.S. Food and Drug Administration  in mid-April to review the results of the study and determine the path forward for efzofitimod in pulmonary sarcoidosis. We plan to pro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4604","BK4555","03160","BK4588","BK4139","ATYR","BK4585","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613075292","title":"aTyr Pharma Awards Inducement Stock Options Under Nasdaq Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613075292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613075292?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:01","pubTimestamp":1771621269,"startTime":"0","endTime":"0","summary":"aTyr Pharma said its board compensation committee granted two new employees nonstatutory stock options covering a total of 12,200 common shares at an exercise price of $0.98 per share. The options vest over four years, with 25% vesting after one year and the remaining 75% vesting in equal monthly installments over the following three years, subject to continued employment. The awards were made under the company’s 2022 Inducement Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aTyr Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL6Kw0J0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","NDAQ","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","SG9999014013.SGD","BK4588","LU2210150020.SGD","BK4139","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","ATYR","SG9999014021.USD","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613629205","title":"aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613629205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613629205?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:01","pubTimestamp":1771621260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA6JTTJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608487190","title":"BRIEF-Atyr Pharma Announces Scheduling Of FDA Type C Meeting To Discuss Efzofitimod Program In Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2608487190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608487190?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:25","pubTimestamp":1770125110,"startTime":"0","endTime":"0","summary":"BRIEF-Atyr Pharma Announces Scheduling Of FDA Type C Meeting To Discuss Efzofitimod Program In Pulmonary SarcoidosisFeb 3 (Reuters) - aTyr Pharma Inc ATYR.O:ATYR PHARMA ANNOUNCES SCHEDULING OF FDA TYP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUABTT2CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2608838879","title":"aTyr Pharma Inc - Type C Meeting Scheduled for Mid-April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608838879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608838879?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:00","pubTimestamp":1770123604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUABTT2CV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608687600","title":"aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2608687600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608687600?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:00","pubTimestamp":1770123604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUABTT2CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}